Clinical Trials

NCT04058990 | ACTIVE_NOT_RECRUITING | NA

180 Participants

Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-12-12

Completion: 2021-12-22

Conditions

Coronary Artery Disease

Interventions

DEVICE

Results Available

NCT04013854 | ACTIVE_NOT_RECRUITING | PHASE2

67 Participants

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2020-01-01

Completion: 2026-08-31

Conditions

Melanoma Stage III Melanoma

Interventions

DRUG

No Results Yet

NCT03998202 | RECRUITING

300 Participants

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Study Type: OBSERVATIONAL

Last Updated: 2025-11-06

Start Date: 2019-09-23

Completion: 2025-12-31

Conditions

Colorectal Cancer Sarcopenia

No Results Yet

NCT03972657 | RECRUITING | PHASE1/PHASE2

345 Participants

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-08-12

Completion: 2027-11-15

Conditions

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Clear Cell Renal Cell Carcinoma (ccRCC)

Interventions

DRUG

No Results Yet

NCT03937973 | COMPLETED | NA

139 Participants

Social Experiences and Sleep Study

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-04-09

Completion: 2025-04-01

Conditions

Sleep Blood Pressure

Interventions

BEHAVIORAL

No Results Yet

NCT03932643 | ACTIVE_NOT_RECRUITING | PHASE1

20 Participants

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-07-30

Completion: 2026-10-31

Conditions

Acute Myeloid Leukemia Myelodysplastic Syndromes

Interventions

DRUG

No Results Yet

NCT03882034 | COMPLETED | PHASE3

12 Participants

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-10-21

Completion: 2025-09-08

Conditions

Pituitary Disease

Interventions

DRUG

No Results Yet

NCT03809533 | ACTIVE_NOT_RECRUITING | PHASE2

30 Participants

The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-05-29

Completion: 2026-04-01

Conditions

Kidney Transplantation Hepatitis C

Interventions

DRUG

No Results Yet

NCT03800693 | RECRUITING | PHASE2

60 Participants

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-03-14

Completion: 2026-08-05

Conditions

Malignant Digestive System Neoplasm

Interventions

DRUG

No Results Yet

NCT03762733 | ENROLLING_BY_INVITATION

500 Participants

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Study Type: OBSERVATIONAL

Last Updated: 2025-11-06

Start Date: 2022-01-04

Completion: 2028-12-29

Conditions

Breast Cancer Ovarian Cancer Uterine Cancer

No Results Yet

NCT03755401 | RECRUITING | NA

75 Participants

Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2018-11-02

Completion: 2027-05-31

Conditions

PTSD

Interventions

OTHER

No Results Yet

NCT03750981 | RECRUITING | NA

500 Participants

C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2018-11-12

Completion: 2027-11-30

Conditions

Cancer Survivors

Interventions

BEHAVIORAL

No Results Yet

NCT03734653 | COMPLETED | EARLY_PHASE1

30 Participants

Testosterone Therapy in Castration Resistant Prostate Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-01-18

Completion: 2024-08-14

Conditions

Prostate Cancer Castration-Resistant Prostate Cancer

Interventions

DRUG

No Results Yet

NCT03715335 | COMPLETED | NA

98413 Participants

Adolescent Sexually Transmitted Infection Screening in the Emergency Department

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2020-07-20

Completion: 2022-09-25

Conditions

Gonorrhea Chlamydia

Interventions

OTHER

Results Available

NCT03710772 | ACTIVE_NOT_RECRUITING | PHASE2

51 Participants

Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-05-01

Completion: 2027-03-22

Conditions

Mantle Cell Lymphoma

Interventions

DRUG BIOLOGICAL

No Results Yet

NCT03696199 | RECRUITING | PHASE4

70 Participants

Randomized Controlled Trial for Ankle Fracture Pain Control

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2020-09-01

Completion: 2026-09-01

Conditions

Ankle Fractures

Interventions

DRUG

No Results Yet

NCT03631225 | ACTIVE_NOT_RECRUITING

1500 Participants

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Study Type: OBSERVATIONAL

Last Updated: 2025-11-06

Start Date: 2019-06-25

Completion: 2026-02-01

Conditions

Rheumatoid Arthritis (RA)

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT03626857 | COMPLETED | NA

129 Participants

MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-02-22

Completion: 2025-01-09

Conditions

Anterior Cruciate Ligament Injury

Interventions

DEVICE OTHER

No Results Yet

NCT03594630 | RECRUITING | EARLY_PHASE1

120 Participants

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2024-03-13

Completion: 2026-10-31

Conditions

Rectal Adenocarcinoma Stage II Rectal Cancer AJCC v8 Stage IIA Rectal Cancer AJCC v8 Stage IIB Rectal Cancer AJCC v8 Stage IIC Rectal Cancer AJCC v8 Stage III Rectal Cancer AJCC v8 Stage IIIA Rectal Cancer AJCC v8 Stage IIIB Rectal Cancer AJCC v8 Stage IIIC Rectal Cancer AJCC v8

Interventions

DRUG OTHER PROCEDURE

No Results Yet

NCT03587116 | COMPLETED | PHASE3

212 Participants

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2018-07-26

Completion: 2024-12-13

Conditions

Hemophilia B Hemophilia A

Interventions

DRUG

Results Available

NCT03548454 | COMPLETED | PHASE4

86 Participants

Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2018-09-20

Completion: 2023-12-24

Conditions

Chronic Pain

Interventions

DRUG

Results Available

NCT03541850 | ACTIVE_NOT_RECRUITING | PHASE2

92 Participants

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2019-01-29

Completion: 2026-11-01

Conditions

PSA Level Greater Than 0.03 PSA Progression Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7 Stage II Prostate Adenocarcinoma AJCC v7 Stage III Prostate Adenocarcinoma AJCC v7

Interventions

DRUG OTHER RADIATION

No Results Yet

NCT03504163 | ACTIVE_NOT_RECRUITING | PHASE2

45 Participants

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2018-06-27

Completion: 2026-04-30

Conditions

Bladder Cancer

Interventions

DRUG

No Results Yet

NCT03312556 | RECRUITING | NA

12 Participants

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2017-09-21

Completion: 2026-09-21

Conditions

Supine Hypertension Autonomic Failure

Interventions

DEVICE DRUG

No Results Yet

NCT03213704 | ACTIVE_NOT_RECRUITING | PHASE2

9 Participants

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2017-08-23

Completion: 2024-09-30

Conditions

Advanced Malignant Solid Neoplasm Recurrent Ependymoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Glioma Recurrent Hepatoblastoma Recurrent Kidney Wilms Tumor Recurrent Langerhans Cell Histiocytosis Recurrent Malignant Germ Cell Tumor Recurrent Malignant Glioma Recurrent Malignant Solid Neoplasm Recurrent Medulloblastoma Recurrent Neuroblastoma Recurrent Non-Hodgkin Lymphoma Recurrent Osteosarcoma Recurrent Rhabdoid Tumor Recurrent Rhabdomyosarcoma Recurrent Soft Tissue Sarcoma Refractory Ependymoma Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Refractory Glioma Refractory Hepatoblastoma Refractory Langerhans Cell Histiocytosis Refractory Malignant Germ Cell Tumor Refractory Malignant Glioma Refractory Malignant Solid Neoplasm Refractory Medulloblastoma Refractory Neuroblastoma Refractory Non-Hodgkin Lymphoma Refractory Osteosarcoma Refractory Primary Central Nervous System Neoplasm Refractory Rhabdoid Tumor Refractory Rhabdomyosarcoma Refractory Soft Tissue Sarcoma

Interventions

PROCEDURE DRUG

Results Available

NCT03173976 | ACTIVE_NOT_RECRUITING | PHASE1

17 Participants

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2017-07-18

Completion: 2023-04-20

Conditions

Chondrosarcoma

Interventions

DRUG

No Results Yet

NCT03033043 | ACTIVE_NOT_RECRUITING | NA

56 Participants

Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2017-12-14

Completion: 2021-10-31

Conditions

Aortic Dissection Type B

Interventions

DEVICE

No Results Yet

NCT02951130 | COMPLETED | PHASE2

66 Participants

Milrinone in Congenital Diaphragmatic Hernia

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2017-10-24

Completion: 2024-09-30

Conditions

Congenital Diaphragmatic Hernia Persistent Pulmonary Hypertension of the Newborn Hypoxemic Respiratory Failure Pulmonary Hypoplasia

Interventions

DRUG

Results Available

NCT02877303 | RECRUITING | PHASE2

80 Participants

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-11-01

Completion: 2026-11-01

Conditions

B Acute Lymphoblastic Leukemia B Lymphoblastic Lymphoma

Interventions

BIOLOGICAL DRUG OTHER

No Results Yet

NCT02842203 | ACTIVE_NOT_RECRUITING

137 Participants

Use of ctDNA for Monitoring of Stage III Colorectal Cancer

Study Type: OBSERVATIONAL

Last Updated: 2025-11-06

Start Date: 2016-09-30

Completion: 2026-09-30

Conditions

Stage III Colorectal Cancer

No Results Yet

NCT02825654 | ENROLLING_BY_INVITATION

6200 Participants

Service and Health Among Deployed Veterans

Study Type: OBSERVATIONAL

Last Updated: 2025-11-06

Start Date: 2018-03-08

Completion: 2027-06-30

Conditions

Pulmonary Function

No Results Yet

NCT02727803 | RECRUITING | PHASE2

100 Participants

Personalized NK Cell Therapy in CBT

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-05-19

Completion: 2027-05-31

Conditions

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia With Myelodysplasia-Related Changes Acute Myeloid Leukemia With Variant MLL Translocations B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Chemotherapy-Related Leukemia Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements ISS Stage II Plasma Cell Myeloma ISS Stage III Plasma Cell Myeloma Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Gene Mutation Myelodysplastic/Myeloproliferative Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Myelodysplastic Syndrome

Interventions

BIOLOGICAL DRUG OTHER RADIATION PROCEDURE

No Results Yet

NCT02716246 | RECRUITING | PHASE2/PHASE3

36 Participants

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-04-25

Completion: 2027-07-31

Conditions

MPS IIIA Sanfilippo Syndrome Sanfilippo A Mucopolysaccharidosis III

Interventions

BIOLOGICAL DRUG

No Results Yet

NCT02684162 | COMPLETED | PHASE2

55 Participants

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-06-22

Completion: 2024-10-08

Conditions

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome

Interventions

BIOLOGICAL DRUG OTHER

Results Available

NCT02616302 | RECRUITING | PHASE2

70 Participants

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2023-02-20

Completion: 2027-10-31

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG

No Results Yet

NCT02615184 | RECRUITING | PHASE2

76 Participants

A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2023-05-23

Completion: 2027-10-31

Conditions

Erosive Esophagitis

Interventions

DRUG

No Results Yet

NCT02603341 | ACTIVE_NOT_RECRUITING | NA

1238 Participants

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-04-06

Completion: 2036-11-30

Conditions

Breast Cancer

Interventions

RADIATION

No Results Yet

NCT02593175 | COMPLETED | PHASE2

43 Participants

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-11-03

Completion: 2025-04-03

Conditions

Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Triple-Negative Breast Carcinoma

Interventions

DRUG BIOLOGICAL

Results Available

NCT02451982 | ACTIVE_NOT_RECRUITING | PHASE2

76 Participants

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2016-03-28

Completion: 2026-05-31

Conditions

Pancreatic Cancer

Interventions

DRUG BIOLOGICAL

No Results Yet

NCT02421380 | RECRUITING | NA

109 Participants

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

Study Type: INTERVENTIONAL

Last Updated: 2025-11-06

Start Date: 2015-04-30

Completion: 2026-04-30

Conditions

Malignant Solid Tumors

Interventions

DRUG

No Results Yet